COMT and betaAR Polymorphism and Development of Painful TMD

COMT和betaAR多态性与痛苦TMD的发展

基本信息

  • 批准号:
    7365142
  • 负责人:
  • 金额:
    $ 33.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-05 至 2010-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by the applicant) Painful temporomandibular disorder (TMD) is a very common orofacial pain condition that affects a large proportion of the human population with a strong bias towards females. The risk of developing TMD and the severity of the disease are associated with a generalized sensitivity to pain. In preliminary studies, we found that specific genetic variants (haplotypes) that code for catecholamine-O-methyltransferase (COMT), an enzyme regulating catecholamine levels, and Beta2-adrenergic receptor (Beta2-AR), a receptor target for epinephrine, are associated with human pain perception and the risk of developing a myogenous TMD. We propose to extend our preliminary assessments of selected SNPs by identifying and functionally characterizing the full haplotype structure of the genes that code for COMT and Beta2-AR. We will identify individual single nucleotide polymorphisms (SNPs) and haplotypes that are associated with pain perception, menstrual cycle related somatic complaints, and the risk of developing myogenous TMD. In order to accomplish this, we will conduct a case-control study on 200 female TMD patients and 200 female control patients. We will also conduct a series of biochemical and molecular biological studies that will examine the mechanisms by which polymorphisms in COMT and Beta2-AR genes affect the biological functions of the respective coded proteins. By elucidating the genetic factors that influence human pain perception, these studies will contribute to our understanding of the pathophysiology underlying myogenous TMD and may lead to new pharmacogenetic approaches to the diagnosis and treatment of TMD patients.
描述:(由申请人提供)疼痛性颞下颌紊乱(TMD)是一种非常常见的口腔面部疼痛疾病,影响了很大一部分人群,其中以女性为主。发生TMD的风险和疾病的严重程度与对疼痛的普遍敏感性有关。在初步研究中,我们发现编码儿茶酚胺- o -甲基转移酶(COMT)(一种调节儿茶酚胺水平的酶)和β 2-肾上腺素能受体(β 2- ar)(一种肾上腺素受体靶点)的特定遗传变异(单倍型)与人类疼痛感知和发生肌源性TMD的风险相关。我们建议通过鉴定和功能表征编码COMT和Beta2-AR的基因的完整单倍型结构来扩展我们对选定snp的初步评估。我们将确定个体单核苷酸多态性(snp)和单倍型,它们与痛觉、月经周期相关的躯体不适以及发生肌源性TMD的风险相关。为此,我们将对200名女性TMD患者和200名女性对照患者进行病例对照研究。我们还将进行一系列生化和分子生物学研究,以检验COMT和Beta2-AR基因多态性影响各自编码蛋白生物学功能的机制。通过阐明影响人类疼痛感知的遗传因素,这些研究将有助于我们了解肌源性TMD的病理生理学基础,并可能为TMD患者的诊断和治疗提供新的药物遗传学方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LUDA DIATCHENKO其他文献

LUDA DIATCHENKO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LUDA DIATCHENKO', 18)}}的其他基金

Biomedical Researcher Development Program in TMJD and Orofacial Pain
颞下颌关节紊乱病和口面部疼痛生物医学研究员发展计划
  • 批准号:
    8527757
  • 财政年份:
    2012
  • 资助金额:
    $ 33.11万
  • 项目类别:
Development of a Novel Class for Opioid Drugs
新型阿片类药物的开发
  • 批准号:
    8451359
  • 财政年份:
    2012
  • 资助金额:
    $ 33.11万
  • 项目类别:
Biomedical Researcher Development Program in TMJD and Orofacial Pain
颞下颌关节紊乱病和口面部疼痛生物医学研究员发展计划
  • 批准号:
    8353144
  • 财政年份:
    2012
  • 资助金额:
    $ 33.11万
  • 项目类别:
Development of a Novel Class for Opioid Drugs
新型阿片类药物的开发
  • 批准号:
    8198849
  • 财政年份:
    2012
  • 资助金额:
    $ 33.11万
  • 项目类别:
Genetic and Psychosocial Influences on Transition to Chronic TMD and Related Pain
遗传和社会心理对慢性 TMD 及相关疼痛的影响
  • 批准号:
    8713244
  • 财政年份:
    2005
  • 资助金额:
    $ 33.11万
  • 项目类别:
COMT and betaAR Polymorphism and Development of Painful TMD
COMT和betaAR多态性与疼痛TMD的发展
  • 批准号:
    7578234
  • 财政年份:
    2005
  • 资助金额:
    $ 33.11万
  • 项目类别:
COMT & betaAR Polymorphism & Development of Painful TMD
COMT
  • 批准号:
    6896271
  • 财政年份:
    2005
  • 资助金额:
    $ 33.11万
  • 项目类别:
COMT and betaAR Polymorphism and Development of Painful*
COMT 和 betaAR 多态性与 Painful* 的发展
  • 批准号:
    7049499
  • 财政年份:
    2005
  • 资助金额:
    $ 33.11万
  • 项目类别:
Genetic and Psychosocial Influences on Transition to Chronic TMD and Related Pain
遗传和社会心理对慢性 TMD 及相关疼痛的影响
  • 批准号:
    8525386
  • 财政年份:
    2005
  • 资助金额:
    $ 33.11万
  • 项目类别:
Genetic and Psychosocial Influences on Transition to Chronic TMD and Related Pain
遗传和社会心理对慢性 TMD 及相关疼痛的影响
  • 批准号:
    8391918
  • 财政年份:
    2005
  • 资助金额:
    $ 33.11万
  • 项目类别:

相似海外基金

Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
  • 批准号:
    10603466
  • 财政年份:
    2023
  • 资助金额:
    $ 33.11万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 33.11万
  • 项目类别:
    Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
  • 批准号:
    RGPIN-2019-04706
  • 财政年份:
    2022
  • 资助金额:
    $ 33.11万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 33.11万
  • 项目类别:
    University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10629280
  • 财政年份:
    2022
  • 资助金额:
    $ 33.11万
  • 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10448574
  • 财政年份:
    2022
  • 资助金额:
    $ 33.11万
  • 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
  • 批准号:
    10591688
  • 财政年份:
    2022
  • 资助金额:
    $ 33.11万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 33.11万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 33.11万
  • 项目类别:
    University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
  • 批准号:
    22K07118
  • 财政年份:
    2022
  • 资助金额:
    $ 33.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了